相关实验视频
Updated: Jan 9, 2026
08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
10.3K
系统分析与dantrolene治疗相关的不良反应:从临床特征到分子机制
Haohui Chen1,2,3, Xulin Zhang1,2, Dongxu Chen1,2
1Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China.
Medicine
|December 10, 2025
概括
丹特罗会引起显著的呼吸和肌肉不良事件,特别是在恶性高温症 (MH) 患者中. 分子分析揭示了这种敏感性增加的机制,表明了特定于MH的剂量策略.
科学领域:
- 药物监督和分子生物学
- 药物安全性和有效性分析
背景情况:
- 丹特罗是一种治疗恶性高温症 (MH),神经乱性恶性综合征和性的关键治疗方法.
- 对丹特罗伦的不良影响和潜在机制的全面分析是有限的.
- 现有的数据缺乏详细的子组分析,特别是将MH患者与非MH患者进行比较.
研究的目的:
- 使用全球药监数据库分析与丹特烯相关的不良事件 (AE).
- 进行一个小组分析,比较MH与非MH患者的AE风险.
- 为了研究底层的分子机制dantrolene相关的AE.
主要方法:
- 从1991-2024年3个主要的药监数据库 (FDA,日本,加拿大) 中对AE的分析.
- 使用报告几率比率 (ROR) 和用于信号检测的其他指数进行不成比例分析.
- 使用基因表达综合 (GEO) 数据集进行差异基因表达分析.
主要成果:
- 与丹特烯相关的重要呼吸道和肌肉骨性副作用,包括呼吸衰竭 (ROR: 29.33-46.29),狂肌溶解 (ROR: 14.05) 和隔间综合征 (ROR: 80.52).
- MH患者的肌肉衰弱 (ROR:19.00),呼吸衰竭 (ROR:5.48) 和肺 (ROR:22.18) 的风险显著增加.
- 分子分析确定了IL6和ALB在呼吸系统效应中,以及Adgrl1/Adgrl2在肌肉功能调节中,突变的诺丁受体1通道在MH患者中加剧了这些效应.
结论:
- 丹特罗与严重的呼吸道和肌肉骨不良事件有关.
- 恶性高温症患者对丹特烯的不良影响表现出不同的敏感性.
- 涉及IL6,ALB,Adgrl1/2和突变的氨酸受体1通道的分子机制解释了MH患者的脆弱性,支持量身定制的剂量策略.
相关概念视频
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
163
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
163
01:29Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175